Caris Life Sciences, Inc.(CAI US)
$32.00+0.290.91%Ext:$30.63-1.384.30%(Market Closed · 23:53:13 UTC)
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY200312/31/2003 | FY200412/31/2004 | FY200512/31/2005 | FY200612/31/2006 | FY200712/31/2007 | FY200812/31/2008 | FY200912/31/2009 | FY201012/31/2010 | FY201112/31/2011 | FY201212/31/2012 | FY201312/31/2013 | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -341.4 | -281.9 | -68.1 | 34.0 | |||||||||||||||||||||
| Depreciation & Amortization | 49.0 | 48.9 | 22.6 | 20.6 | |||||||||||||||||||||
| Stock Based Compensation | 15.2 | 18.6 | 70.0 | 55.3 | |||||||||||||||||||||
| Change in Working Capital | -7.1 | -29.1 | -33.1 | -38.2 | |||||||||||||||||||||
| Other Non-Cash Items | 8.2 | -1.8 | 91.7 | 75.6 | |||||||||||||||||||||
| Net Cash from Operating Activities | -276.1 | -245.2 | 83.2 | 147.4 | |||||||||||||||||||||
| -Investments in Property, Plant & Equipment | -22.3 | -8.4 | -16.3 | -23.9 | |||||||||||||||||||||
| -Acquisitions Net | - | - | - | - | |||||||||||||||||||||
| -Purchases of Investments | -63.4 | - | - | - | |||||||||||||||||||||
| Sales/Maturities of Investments | 300.5 | 61.4 | - | - | |||||||||||||||||||||
| Other Investing Activities | - | - | - | - | |||||||||||||||||||||
| Net Cash from Investing Activities | 214.8 | 52.9 | -16.3 | -23.9 | |||||||||||||||||||||
| Net Debt Issuance | 10.6 | 199.8 | 16.0 | 27.7 | |||||||||||||||||||||
| Net Stock Issuance | - | - | 667.5 | -0.4 | |||||||||||||||||||||
| -Net Dividends Paid | - | - | - | - | |||||||||||||||||||||
| Other Financing Activities | -0.4 | 0.5 | -18.6 | 637.2 | |||||||||||||||||||||
| Net Cash from Financing Activities | 10.1 | 200.3 | 665.0 | 664.5 | |||||||||||||||||||||
| Effect of Forex Changes | 0.1 | -0.0 | 0.1 | 0.1 | |||||||||||||||||||||
| Net Change in Cash | -51.1 | 8.0 | 732.0 | 788.1 | |||||||||||||||||||||
| Cash at End of Period | 60.0 | 68.0 | 800.0 | 3,100.9 | |||||||||||||||||||||
| Operating Cash Flow | -276.1 | -245.2 | 83.2 | 147.4 | |||||||||||||||||||||
| -Capital Expenditure | -22.3 | -8.4 | -16.3 | -23.9 | |||||||||||||||||||||
| Free Cash Flow | -298.4 | -253.6 | 66.9 | 123.5 | |||||||||||||||||||||